Bio-Thera Solutions Hits Day High with Strong 8.73% Intraday Surge

Bio-Thera Solutions, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock price, gaining 8.73% on March 27, 2026. The stock reached an intraday high of CNY 22.46, marking a notable performance against the backdrop of the China Shanghai Composite, which only saw a modest increase of 0.63% on the same day. Over the past week, Bio-Thera Solutions has shown a slight improvement of 0.95%, contrasting with a decline of 1.09% in the broader market. However, its performance over the past month reflects a decrease of 3.67%, while the one-year performance stands at a gain of 10.62%, albeit underperforming the China Shanghai Composite's 16.01% increase. Despite today's positive movement, the company faces challenges, including a low Return on Capital Employed (ROCE) of 1.31% and a high debt-equity ratio of 79.01%. These factors contribute to a complex financial landscape for Bio-Thera Solutions, which has reported negative results for the last three consecutive quarters.